Robuta

https://pubmed.ncbi.nlm.nih.gov/38783008/
Hand osteoarthritis (OA) is an irreversible degenerative condition causing chronic pain and impaired functionality. Existing treatment options are often...
open labelfeasibility trialtransdermalcannabidiolhand
https://www.uclahealth.org/clinical-trials/global-open-label-extension-study-del-desiran-treatment-dm1
open label extensionneurological diseasesclinical trialbrainucla
https://pubmed.ncbi.nlm.nih.gov/29861076/
Italian Medicine Agency.
long termdecompensated cirrhosisalbuminadministrationanswer
https://pubmed.ncbi.nlm.nih.gov/39797584/
protocolyearrandomisedcontrolledparallel
https://pubmed.ncbi.nlm.nih.gov/12006124/
The results of this study suggest that MSM supplementation of 2,600 mg/day for 30 days may be efficacious in the reduction of symptoms associated with SAR....
open label trialsafetyefficacy
https://pubmed.ncbi.nlm.nih.gov/26396517/
BLT combined with the ongoing pharmacological treatment offers a simple approach, and it might be effective in rapidly ameliorating depressive core symptoms of...
light therapyaugmentationdifficulttreatdepressed
https://www.yalemedicine.org/clinical-trials/bi-1703880-in-combination-with-ezabenlimab-in-advanced-solid-tumours
This study is open to adults with different types of advanced cancer. People can take part if previous treatment was not successful, or no treatment exists....
phase iaopen labelfirsthumandose
https://www.iasp-pain.org/publications/pain-research-forum/papers-of-the-week/paper/142244-open-label-randomised-multicentre-crossover-trial-assessing-two-layer-compression/
Compression bandaging is the mainstay therapy for chronic venous insufficiency and venous leg ulcers, but patient compliance can be challenging due to...
open labelcrossover trialtwo layerrandomisedassessing
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2016-0128.html
The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete...
phase iiaopen labelclinical trialevaluate